CN101080384B - N-取代的水杨酰胺的制备方法 - Google Patents

N-取代的水杨酰胺的制备方法 Download PDF

Info

Publication number
CN101080384B
CN101080384B CN2005800431247A CN200580043124A CN101080384B CN 101080384 B CN101080384 B CN 101080384B CN 2005800431247 A CN2005800431247 A CN 2005800431247A CN 200580043124 A CN200580043124 A CN 200580043124A CN 101080384 B CN101080384 B CN 101080384B
Authority
CN
China
Prior art keywords
formula
compound
alkyl
ethyl
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2005800431247A
Other languages
English (en)
Chinese (zh)
Other versions
CN101080384A (zh
Inventor
B·里斯
U·迈尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34090175&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN101080384(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis AG filed Critical Novartis AG
Publication of CN101080384A publication Critical patent/CN101080384A/zh
Application granted granted Critical
Publication of CN101080384B publication Critical patent/CN101080384B/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/60—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/24—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26—Two oxygen atoms, e.g. isatoic anhydride

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN2005800431247A 2004-12-16 2005-12-14 N-取代的水杨酰胺的制备方法 Expired - Fee Related CN101080384B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0427603.6A GB0427603D0 (en) 2004-12-16 2004-12-16 Organic compounds
GB0427603.6 2004-12-16
PCT/EP2005/013454 WO2006063821A1 (en) 2004-12-16 2005-12-14 Manufacture process of n-substituted salicylamides

Publications (2)

Publication Number Publication Date
CN101080384A CN101080384A (zh) 2007-11-28
CN101080384B true CN101080384B (zh) 2011-06-15

Family

ID=34090175

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2005800431247A Expired - Fee Related CN101080384B (zh) 2004-12-16 2005-12-14 N-取代的水杨酰胺的制备方法

Country Status (24)

Country Link
US (1) US8461385B2 (enExample)
EP (2) EP1838664B1 (enExample)
JP (1) JP5224816B2 (enExample)
KR (1) KR101287233B1 (enExample)
CN (1) CN101080384B (enExample)
AR (1) AR055007A1 (enExample)
AU (1) AU2005315850B2 (enExample)
BR (1) BRPI0519327A2 (enExample)
CA (1) CA2587213C (enExample)
ES (1) ES2547349T3 (enExample)
GB (1) GB0427603D0 (enExample)
GT (1) GT200500353A (enExample)
IL (1) IL183366A0 (enExample)
MA (1) MA29092B1 (enExample)
MX (1) MX2007007211A (enExample)
NO (1) NO338969B1 (enExample)
PE (1) PE20060740A1 (enExample)
PL (1) PL1838664T3 (enExample)
PT (1) PT1838664E (enExample)
RU (1) RU2404158C2 (enExample)
TN (1) TNSN07229A1 (enExample)
TW (1) TW200635880A (enExample)
WO (1) WO2006063821A1 (enExample)
ZA (1) ZA200703826B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101627011A (zh) 2005-09-19 2010-01-13 爱密斯菲尔科技公司 N-(5-氯水杨酰基)-8-氨基辛酸的二钠盐的晶形
PL2215047T3 (pl) 2007-11-02 2014-05-30 Emisphere Tech Inc Sposób leczenia niedoborów witaminy b12
CN109473182B (zh) * 2018-11-12 2021-10-19 北京北排科技有限公司 一种基于深度信念网络的mbr膜透水率智能检测方法
CA3141383A1 (en) * 2019-05-20 2020-11-26 Lonza Guangzhou Pharmaceutical Ltd. Method for preparation of carsalam
CN115260116B (zh) * 2022-08-19 2024-04-12 株洲壹诺生物技术有限公司 8-(2-羟基苯甲酰胺基)辛酸钠及苯并噁嗪-2,4-二酮和8-溴辛酸乙酯的制法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU382610A1 (ru) * 1968-07-08 1973-05-25 Способ получения амидов карбоновых кислот
DE60017888T2 (de) 1999-04-05 2006-01-19 Emisphere Technologies, Inc. Dinatrium-salze, monohydrate und ethanol-solvate
TR200200619T2 (tr) * 1999-06-25 2003-01-21 The Institutes For Pharmaceutical Discovery, Llc. İkame edilmiş fenoksiasetik asitler.
ES2386263T3 (es) 2000-03-21 2012-08-14 Emisphere Technologies, Inc. Método de preparación de salicilamidas alquiladas mediante un producto intermedio de dicarboxilato
US7262325B2 (en) 2000-06-02 2007-08-28 Emisphere Technologies, Inc. Method of preparing salicylamides
WO2003057650A2 (en) * 2002-01-09 2003-07-17 Emisphere Technologies, Inc. Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate
EP1299348B1 (en) * 2000-06-29 2008-04-09 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US7495030B2 (en) * 2000-09-06 2009-02-24 Emisphere Technologies, Inc. (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
US7049283B2 (en) * 2000-12-06 2006-05-23 Novartis Ag Pharmaceutical compositions for the oral delivery of pharmacologically active agents
JP4417113B2 (ja) * 2002-02-20 2010-02-17 エミスフェアー・テクノロジーズ・インク Ｇｌｐ−１分子の投与方法
US20050054557A1 (en) * 2002-05-09 2005-03-10 Goldberg Michael M. Compositions for delivering parathyroid hormone and calcitonin

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
实施例2.
邢其毅 等.基础有机化学 第2版.高等教育出版社,1993,145页.
邢其毅等.基础有机化学 第2版.高等教育出版社,1993,145页. *

Also Published As

Publication number Publication date
PL1838664T3 (pl) 2016-04-29
NO338969B1 (no) 2016-11-07
AR055007A1 (es) 2007-08-01
NO20073548L (no) 2007-09-17
BRPI0519327A2 (pt) 2009-01-13
TNSN07229A1 (en) 2008-11-21
IL183366A0 (en) 2007-09-20
GB0427603D0 (en) 2005-01-19
RU2404158C2 (ru) 2010-11-20
CN101080384A (zh) 2007-11-28
JP5224816B2 (ja) 2013-07-03
JP2008524142A (ja) 2008-07-10
EP2955171A1 (en) 2015-12-16
GT200500353A (es) 2006-07-17
MX2007007211A (es) 2007-08-15
RU2007126972A (ru) 2009-01-27
EP1838664B1 (en) 2015-07-15
TW200635880A (en) 2006-10-16
ES2547349T3 (es) 2015-10-05
ZA200703826B (en) 2008-08-27
US20090253811A1 (en) 2009-10-08
MA29092B1 (fr) 2007-12-03
AU2005315850A1 (en) 2006-06-22
KR20070086276A (ko) 2007-08-27
PE20060740A1 (es) 2006-09-04
CA2587213A1 (en) 2006-06-22
PT1838664E (pt) 2015-10-16
US8461385B2 (en) 2013-06-11
EP1838664A1 (en) 2007-10-03
WO2006063821A1 (en) 2006-06-22
AU2005315850B2 (en) 2009-11-05
KR101287233B1 (ko) 2013-07-17
CA2587213C (en) 2015-05-19

Similar Documents

Publication Publication Date Title
CN101080384B (zh) N-取代的水杨酰胺的制备方法
US20080171891A1 (en) Process for preparing carbamic ester derivatives
RU2214998C2 (ru) Способ получения 3-циано-2,4-дигалоген-5-фторбензойных кислот (варианты) и промежуточные соединения
US8013184B2 (en) Manufacture process of organic compounds
EP1611084A1 (en) Process for the manufacture of n-alkoxalyl-alaninates
JPH10101627A (ja) ３−アミノ−４，４，４−トリハロクロトネート化合物の製造方法
JP2006500409A (ja) Ｎｏ供与ジクロフェナクのようなｎｏ供与化合物の製造方法
JP2886908B2 (ja) ３―クロロ―２，４，５―トリフルオロ安息香酸の改良合成方法
KR20040039430A (ko) (2-니트로페닐)아세토니트릴 유도체의 제조방법 및 그합성중간체
KR100207247B1 (ko) 아닐리노푸 마르산염의 제조 방법
EP0638065B1 (en) A process for the preparation of 3- and/or 5-substituted anthranilic acids
JP3537489B2 (ja) Ｎ−長鎖アシルアミノ酸及びその塩の製造法、並びに中間体アミドニトリル、及びその製造法
JPH0576473B2 (enExample)
JPH0321538B2 (enExample)
US4084057A (en) Process for the production of 4-acylamido-4, 4-dicarbalkoxy-butanalphenylhydrazone
KR800001177B1 (ko) 초산유도체류의 제조방법
JPH1180076A (ja) ２，３，４−トリフルオロ−５−ヨ−ド安息香酸、そのエステル類及びその製造法
JPH09316021A (ja) α−分枝長鎖脂肪酸の製造法
KR20080046175A (ko) 1,2-벤지속사졸-3-아세트산의 술폰화법

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee

Owner name: NOVARTIS CO., LTD.

Free format text: FORMER NAME: NOVARTIS AG

CP01 Change in the name or title of a patent holder

Address after: Basel

Patentee after: Novartis Ag

Address before: Basel

Patentee before: Novartis AG

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110615

Termination date: 20171214

CF01 Termination of patent right due to non-payment of annual fee